Sever Pharma Solutions AB
FDA inspection history in Malmo, Sweden, 2017
- 1
- Form 483
Every document, by year
- Form 483
2017: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2017One Form 483, at Malmo, Sweden.
Cited most
Across all Sever Pharma Solutions AB observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.180General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.65Equipment construction1
The complete Sever Pharma Solutions AB file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Malmo, Sweden
One Form 483 · 2017 · 4 observations
Latest: Form 483, Dec 15, 2017 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2017-12-15 | 483 Form 483 | Malmo, Sweden | 4 | $99 |
Investigators on these documents
FEI number 3004620701 · most recent document Dec 15, 2017
About Sever Pharma Solutions AB
How many FDA Form 483s has Sever Pharma Solutions AB received?
FDA Intel has 1 Form 483 on file for Sever Pharma Solutions AB; the most recent is dated Dec 15, 2017.
When was Sever Pharma Solutions AB last inspected by FDA?
The most recent FDA inspection document on file for Sever Pharma Solutions AB is a Form 483 dated Dec 15, 2017, for the site in Malmo, Sweden.
What did FDA cite at Sever Pharma Solutions AB?
The regulations cited most in the observations on file for Sever Pharma Solutions AB are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.180 (General requirements), 1 time; 21 CFR 211.192 (Production record review), 1 time.